Chairman and Co-Founder
Peter Friedli, who has been head of the Swiss venture capital firm Friedli Corporate Finance AG since 1986, has more than 36 years of entrepreneurial experience as an independent venture capital investment manager and specializes in high-tech investments, primarily in biotechnology and high-tech. He has invested in more than 170 venture companies ranging from start-up to IPO with the majority of companies domiciled in the United States. He was a co-founder and the Chairman of Osiris Therapeutics as well as the major shareholder. He previously worked in international management consulting for service and industrial companies in Europe and the United States.